7:15 – 8:15 am
MORNING NETWORKING
8:10 – 8:30 am
MISSION, GOALS AND OBJECTIVES OF RAISE 2026
Chairs: M. Edip Gurol (Neurology, MGB/HMS)
8:30 - 10:05 am
SESSION 1: ARTIFICIAL INTELLIGENCE IN STROKE PREVENTION
Co-Chairs: Dawn Kleindorfer (Neurology, U. Michigan)
Cheryl Bushnell (Neurology, Wake Forest)
8:15 – 8:27 am WEARABLES FOR STROKE PREVENTION
TBA
8:27 – 8:39 am AI-BASED ALGORITHMS FOR CLINICAL DECISION MAKING
TBA
8:39 – 8:51 am AI-POWERED DEVICES FOR DIAGNOSTICS/SCREENING
TBA
8:51 – 9:03 am AI AND BIG DATA IN STROKE PREVENTION RESEARCH
Nassir Marrouche (Cardiac EP, Tulane Univ.)
9:03 – 9:09 am TBA
9:09 – 9:15 am TBA
9:15 – 10:05 am PANEL DISCUSSION
Jose Merino (Neurology, Georgetown)
10:05 – 10:25 am
BREAK
10:25 – 12:15 pm
SESSION 2: ATRIAL FIBRILLATION DETECTION
Co-Chairs: Magdy Selim (Neurology, BIDMC/HMS)
Clinton Wright (NINDS)
10:25 – 10:37 am OPPORTUNISTIC MONITORING FOR AF
Tina Baykaner (Cardiac EP, Stanford)
10:37 – 10:49 am AF MONITORING WITH EXTERNAL DEVICES
Mintu Turakhia (Cardiac EP, Stanford)
10:49 – 11:01 am INSERTABLE CARDIAC MONITORS
Suneet Mittal (Cardiac EP, Valley Health System, NY)
11:01 – 11:13 am INTEGRATING DIFFERENT METHODS FOR BEST YIELD IN
PRIMARY & SECONDARY PREVENTION
M. Edip Gurol(Neurology, MGB/HMS)
11:13 – 11:19 am TBA
11:19 – 11:25 am TBA
11:25 – 12:15 pm PANEL DISCUSSION
12:15 – 1:15 pm
BREAK
1:15 – 3:05 pm
SESSION 3: PREVENTING STROKE AND COGNITIVE IMPAIRMENT IN ATRIAL FIBRILLATION WITHOUT INCREASING BLEEDING RISK EXCESSIVELY
Co-Chairs: Scott Janis (NINDS)
1:15 – 1:27 pm UNDERSTANDING HEMORRHAGE RISK AND ITS IMPACT IN
AF MANAGEMEN
M. Edip Gurol(Neurology, MGB/HMS)
1:27 – 1:39 pm FACTOR XIA INHIBITORS IN AFIB
Carolyn Lam (Cardiology, Duke-NUS)
1:39 – 1:51 pm LEFT ATRIAL APPENDAGE CLOSURE (LAAC) FOR STROKE PREVENTION IN
AFIB: A DEEP DIVE IN NEW RCT RESULTS
Martin B. Leon (Cardiology, Columbia)
1:51 – 2:03 pm COMBINING ABLATION AND LAAC: IMPACT ON STROKE PREVENTION
Vivek Reddy (AHA)
2:03 – 2:09 pm TBA
2:09 – 2:15 pm TBA
2:15 – 3:05 pm PANEL DISCUSSION
3:05 – 3:20 pm
BREAK
3:20 – 5:10 pm
SESSION 4: UPDATES ON ANTITHROMBOTICS IN STROKE PREVENTION: FOCUS ON FACTOR XIA INHIBITORS
Co-Chairs: Dawn Kleindorfer (Neurology, U. Michigan)
Cheryl Bushnell (Neurology, Wake Forest)
3:20 – 3:32 pm UNDERSTANDING OUR FAILURES IN SECONDARY STROKE
PREVENTION AND THE NEED FOR NEW STRATEGIES
Hooman Kamel (Neurology, Cornell)
3:32 – 3:44 pm THE CONCEPT OF “HEMOSTASIS-SPARING”
ANTITHROMBOTICS:FACTOR XIA INHIBITION AND
BEYOND
TBA
3:44 – 3:56 pm A DEEP DIVE IN OCEANIC-STROKE RESULTS
Mike Sharma (Neurologist, PHRI/McMasters, Hamilton, Canada)
3:56 – 4:08 pm UPDATES ON EXISTING ANTIPLATELETS AND ANTICOAGULANTS
TBA
4:08 – 4:14 pm TBA
4:14 – 4:20 pm TBA
4:20 – 5:10 pm PANEL DISCUSSION
6:30 – 9:30 pm
EVENING OF NETWORKING: BUILDING CONNECTIONS AND OPPORTUNITIES FOLLOWED BY SPECIAL PRESENTATION
TBA
8:15 – 8:27 am WEARABLES FOR STROKE PREVENTION
TBA
8:27 – 8:39 am AI-BASED ALGORITHMS FOR CLINICAL DECISION MAKING
TBA
8:39 – 8:51 am AI-POWERED DEVICES FOR DIAGNOSTICS/SCREENING
TBA
8:51 – 9:03 am AI AND BIG DATA IN STROKE PREVENTION RESEARCH
Nassir Marrouche (Cardiac EP, Tulane Univ.)
9:03 – 9:09 am TBA
9:09 – 9:15 am TBA
9:15 – 10:05 am PANEL DISCUSSION
Jose Merino (Neurology, Georgetown)
7:15 – 8:15 am
MORNING NETWORKING
8:15 – 10:05 am
SESSION 5: ADVANCES IN RISK FACTOR MODIFICATION for Stroke Prevention
Co-Chairs: Dawn Kleindorfer (Neurology, U. Michigan)
Cheryl Bushnell (Neurology, Wake Forest)
8:15 – 8:27 am GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS FOR STROKE PREVENTION
Eda Cengiz (Endocrinology, UCSF)
8:27 – 8:39 am NEXT-GENERATION HYPERTENSION MANAGEMENT
TBA
8:39 – 8:51 am UNDERSTANDING LIPOPROTEIN (A) AND ITS INHIBITORS
TBA
8:51 – 9:03 am PCSK9 INHIBITORS FOR STROKE PREVENTION
TBA
9:03 – 9:09 am TBA
9:09 – 9:15 am TBA
9:15 – 10:05 am PANEL DISCUSSION
10:05 – 10:25 am
BREAK
10:25 – 12:15 pm
SESSION 6: UPDATES ON DEVICES FOR STROKE PREVENTION
Co-Chairs: Magdy Selim (Neurology, Harvard Medical School)
Clinton Wright (NINDS)
10:25 – 10:37 am BETTER SCREENING FOR PFO: IMPLICATIONS FOR CLINICAL CARE
AND RESEARCH
TBA
10:37 – 10:49 am NEW/POTENTIAL STUDIES IN PFO Closure
Jeff Saver (Neurology, UCLA)
10:49 – 11:01 am LEFT ATRIAL APPENDAGE THROMBUS FORMATION IN PATIENTS
WITHOUT KNOWN AFIB
Luciano Sposato (Neurology, Western University, Canada)
11:01 – 11:13 am PROPHYLACTIC ABLATION AND LAA OBLITERATION DURING MAJOR
CARDIAC SURGERY
TBA
11:13 – 11:19 am TBA
11:19 – 11:25 am TBA
11:25 – 12:15 pm PANEL DISCUSSIO
12:15 – 1:15 pm
BREAK
1:15 – 3:05 pm
SESSION 7: SPECIAL CASES IN PREVENTION OF ISCHEMIC AND HEMORRHAGIC STROKES
Co-Chairs: Scott Janis (NINDS)
1:15 – 1:27 pm CAROTID ARTERY DISEASE IN 2026: FROM DETECTION TO TREATMENT
TBA
1:27 – 1:39 pm CREST2 RESULTS AND ITS IMPLICATIONS FOR CAROTID STENTING
TBA
1:39 – 1:51 pm STROKE PREVENTION IN HEART FAILURE
Faiez Zannad(Cardiology, Nancy, France)
1:51 – 2:03 pm ATRIAL FIBRILLATION AND COGNITIVE IMPAIRMENT
Rebecca Gottesman (NINDS)
2:03 – 2:09 pm TBA
2:09 – 2:15 pm TBA
2:15 – 3:05 pm PANEL DISCUSSION
3:05 – 3:20 pm
BREAK
3:20 – 4:30 pm
WORKSHOPS TO DEVELOP CONSENSUS RECOMMENDATIONS
Participants are divided into three groups, each to develop recommendations.
WORKSHOP #1: PREVENTION OF ISCHEMIC STROKES AND HEMORRHAGES IN ATRIAL FIBRILLATION
WORKSHOP #2: CUTTING EDGE MEDICAL TREATMENTS FOR NON-AFIB STROKE PREVENTION
WORKSHOP #3: UPDATES ON DEVICES FOR NON-AFIB STROKE PREVENTION
4:30 – 4:45 pm
BREAK
4:45 – 6:00 pm
WORKSHOP CHAIRS PRESENT RECOMMENDATIONS TO FULL ASSEMBLY
Drafting of consensus statement is initiated
Chaired by M. Edip Gurol (MGH/HMS)